Veradigm | MDRX - Market Capitalization


Veradigm reported $531.2M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 141.01M 6.71M Dec/2025
Ambu A/S DKK 20.93B 4.51B Nov/2026
Amplifon EUR 2.57B 714.49M Nov/2026
Cardinal Health USD 64.82B 13.29B Nov/2026
Centene USD 33.38B 2.69B Nov/2026
Charles River Laboratories USD 16.69B 2.7B Nov/2026
Cigna USD 83.86B 12.03B Nov/2026
Coloplast 124.69B 775.88M Dec/2025
CVS Health USD 100.62B 8.97B Nov/2026
Diasorin EUR 4.26B 471.02M Nov/2026
Elevance Health USD 84.32B 340M Sep/2026
General Electric Aerospace USD 324.02B 65.91B Sep/2026
Gulf Medical Proj AED 1.67B 314.51M Mar/2026
Humana USD 51.1B 3.41B Nov/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Laboratory Of America USD 24.99B 2.03B Sep/2026
Max Healthcare Institute Limited 904.98B 194.05B Sep/2026
Maximus USD 2.82B 672M Jun/2026
McKesson USD 140.53B 40.99B Nov/2026
Med Life RON 6.23B 2.07B Mar/2026
Molina Healthcare USD 9.87B 2.04B Sep/2026
Omnicell USD 1.55B 335M Sep/2026
Oriola-kd EUR 166.42M 8.71M Sep/2026
Owens Minor USD 217M 154M Dec/2025
Quest Diagnostics USD 25.72B 2.26B Sep/2026
Rede D'or Sao Luiz BRL 77.76B 11.45B Jun/2026
Siemens Healthineers EUR 49.01B 6.18B Nov/2026
Supermax Corporation Bhd MYR 1.2B 371.97M Nov/2026
UnitedHealth USD 329.49B 47.96B Sep/2026
Veeva Systems USD 33.1B 7.65B Jun/2026
Veradigm USD 525M 621M Mar/2026